Mind-wandering and Predictive Processes in Narcolepsy: a Putative Mechanism Through Covert REM Intrusions

Recruiting N/A Interventional Study
Narcolepsy Type 1 Hypersomnolence Idiopathic Hypersomnia
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 65
Sex
Any
Study type
Interventional
Purpose
Basic Science
Participants needed
180 (estimated)
Sponsor
Hospices Civils de Lyon · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Mind wandering is a state in which attention turns away from the external environment or current task to focus on internal thoughts (past experiences, future events, planned actions...). Humans are thought to spend at least one third of their waking lives in this state. Mind wandering can be assessed experimentally by investigating mental content during well-controlled tasks. In this case, task-un…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Patients with NT1 or IH diagnosis according to ICSD3-TR criteria (American Academy of Sleep, 2023) * For patient with IH: with abnormal Mean Sleep Latency Test (MSLT) (mean latency ≤ 8 min, ≤ 1 SOREMp) * Patients with subjective hypersomnolence without underlying cause (negati…
Contacts

Laure PETER-DEREX, Professor

+33 04 72 07 19 29

laure.peter-derex@chu-lyon.fr

CONTACT

Dezső NEMETH, PhD

nemethd@gmail.com

CONTACT